4-(4-METHYLTHIAZOL-5-YL)BENZONITRILE, 95.0%, 500mg

(S)-5-(1,2-Dithiolan-3-yl)pentanoic acid, 95.0%, 250mg

Ethyl 2-(4-methoxyphenoxy)acetate, 1g

DL-Limonene, min. 95%, 250 ml, glass packaging

2-Fluoro-6-picoline-5-boronic acid, 95.0%, 1g

Ethyl 3-(N-butyl-4-methylbenzamido)propanoate, 97%, 100mg

2-((3-Chlorophenyl)amino)-4-methyl-1,3-thiazole-5-carboxylic acid, 95%, 1g

Imidazol-1-yl-acetonitrile, 95.0%, 5g

rac-(1R,5S,6S)-3-azabicyclo[3.2.0]heptan-6-ol hydrochloride, 95.0%, 250mg

7-Azaindole-3-carboxaldehyde, 98.0%, 10g

3-methyl-1-(3,4,5-trimethoxybenzoyl)piperazine, 95.0%, 1g

(2E)-1-(3-bromophenyl)-3-(furan-2-yl)prop-2-en-1-one, 95.0%, 10g

1,2-Phenylenediamine [for Biochemical Research]>98.0%(GC)(T)5g